Form 4 for OGN Organon & Co.
Accepted 2025-04-02 00:00:00 ET · period of report 2025-03-31 · accession 0001861045-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-02 | 2025-03-31 | OGN | DiMarco Kathryn | Corp. Ctrl | M - OptEx | $0.00 | +23.4K | 34.0K | +222% | $0 |
| DM | 2025-04-02 | 2025-03-31 | OGN | DiMarco Kathryn | Corp. Ctrl | F - Tax | $14.51 | -8,028 | 35.9K | -18% | -$116.5K |
| DM | 2025-04-02 | 2025-03-31 | OGN | DiMarco Kathryn | Corp. Ctrl | M - OptEx | $0.00 | -23.4K | 0 | -100% | $0 |
| D | 2025-04-02 | 2025-03-31 | OGN | DiMarco Kathryn | Corp. Ctrl | A - Grant | $0.00 | +40.3K | 40.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-31 | M | A | 4,294 | $0.00 | 40,211 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-31 | M | A | 8,503 | $0.00 | 38,830 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-31 | F | D | 3,644 | $14.51 | 30,327 | D | — | — | (F1) This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. |
| 4 | Common | Common Stock | 2025-03-31 | M | A | 10,638 | $0.00 | 33,971 | D | — | — | |
| 5 | Common | Common Stock | 2025-03-31 | F | D | 1,471 | $14.51 | 38,740 | D | — | — | (F1) This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. |
| 6 | Common | Common Stock | 2025-03-31 | F | D | 2,913 | $14.51 | 35,917 | D | — | — | (F1) This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. |
| 7 | Derivative | Restricted Stock Units | 2025-03-31 | M | D | 8,503 | $0.00 | 8,504 | D | — · — to — | 8,503 Common Stock | (F2) Each RSU converts into one share of Organon common stock. (F5) On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026. |
| 8 | Derivative | Restricted Stock Units | 2025-03-31 | M | D | 10,638 | $0.00 | 21,276 | D | — · — to — | 10,638 Common Stock | (F2) Each RSU converts into one share of Organon common stock. (F4) On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day. |
| 9 | Derivative | Restricted Stock Units | 2025-03-31 | A | A | 40,295 | $0.00 | 40,295 | D | — · — to — | 40,295 Common Stock | (F2) Each RSU converts into one share of Organon common stock. (F3) The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028. |
| 10 | Derivative | Restricted Stock Units | 2025-03-31 | M | D | 4,294 | $0.00 | 0 | D | — · — to — | 4,294 Common Stock | (F2) Each RSU converts into one share of Organon common stock. (F6) On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested. |